Biodeal Pharmaceuticals Limited, a active public limited company, was established on 30 December 2005 in Nalagarh, Distt. Solan (Hp)., Himachal Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U00304HP2005PLC029451. Registered under ROC Roc Himachal Pradesh. it is unlisted. It has an authorized capital of ₹25.45 Cr and a paid-up capital of ₹25.34 Cr.
It upholds a compliant status. Employing 343 professional, Its leadership includes Dev Datt (Director), Anurag Kumar (Managing Director), Anchal Kumari (Director). Past directors included Gurudutta Mishra, Dev Datt, Swati Tiwari. It holds ₹212.08 Cr open charges and ₹122.92 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Village Saini Majra,Nalagarh-Ropar Road, Teh. Nalagarh, Distt. Solan (Hp)., Nalagarh, Distt. Solan (Hp)., Himachal Pradesh.
U00304HP2005PLC029451
029451
30 December 2005
₹25.45 Cr
₹25.34 Cr
Roc Himachal Pradesh
Unlisted
Active
Explore comprehensive insights into Biodeal Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dev Datt | Director | 01 Apr 2021 | Current |
| Anurag Kumar | Managing Director | 31 Dec 2020 | Current |
| Anchal Kumari | Director | 30 Nov 2022 | Current |
| Noopur Jha | Director | 14 Jun 2024 | Current |
| Abhishek Jain | Nominee Director | 16 May 2025 | Current |
| Adheesh Chander Malhotra | Additional Director | 20 Jun 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Nominee Director | 24 Apr 2025 | Past |
| Pramod Abcsdd | Whole-Time Director | 31 Oct 2023 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 14 Mar 2023 | Past |
| Pramod Abcsdd | Additional Director | 27 Apr 2023 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Biodeal Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 41.92% increase. The company also saw a substantial improvement in profitability, with a 90.53% increase in profit. The company's net worth Soared by an impressive increase of 21.33%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Biodeal Pharmaceuticals had a promoter holding of 99.88% and a public holding of 0.12%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,120,845,000.00
₹1,229,182,431.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Oct 2025 | Axis Bank Limited | ₹50.00 Cr | Open |
| 25 Sep 2025 | Hdfc Bank Limited | ₹1.31 Cr | Open |
| 29 Aug 2025 | Hdfc Bank Limited | ₹3.14 M | Open |
| 06 May 2025 | Hdfc Bank Limited | ₹1.14 M | Open |
| 21 Feb 2025 | Hdfc Bank Limited | ₹2.46 M | Open |
Explore comprehensive loan charge details -
Biodeal Pharmaceuticals has a workforce of 343 employees as of Apr 10, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Biodeal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biodeal Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 18 Jan 2022 via Charge ID 100527051 with Sidbi was fully satisfied on 20 Nov 2025. was recorded as a recent event.
Sanjay Kumar Sharma was appointed as a Ceo was appointed as a Ceo on 07 Nov 2025 & has been associated with this company since 2 months 11 days . was recorded as a recent event.
Progress on A charge with Axis Bank Limited amounted to Rs. 50.00 Cr with Charge ID 101182326 was registered on 18 Oct 2025. was documented.
Progress on Rishi Kapoor was appointed as a Cfo was appointed as a Cfo on 04 Oct 2025 & has been associated with this company since 3 months 14 days . was documented.
Progress on Biodeal Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 1.31 Cr with Charge ID 101188927 was registered on 25 Sep 2025. was completed.
The CIN of Biodeal Pharmaceuticals Limited is U00304HP2005PLC029451.
Biodeal Pharmaceuticals Limited is headquartered at Village Saini Majra,Nalagarh-Ropar Road, Teh. Nalagarh, Distt. Solan (Hp)., Nalagarh, Distt. Solan (Hp)., Himachal Pradesh.
Biodeal Pharmaceuticals Limited was incorporated on 30 December 2005.
The current directors of Biodeal Pharmaceuticals Limited are
The primary industry of Biodeal Pharmaceuticals Limited is Manufacturing.
Biodeal Pharmaceuticals Limited is unlisted.
The authorized capital of Biodeal Pharmaceuticals Limited is ₹25.45 Cr, and the paid-up capital is ₹25.34 Cr.
The compliance status of Biodeal Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX